Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HX575 for chemotherapy-associated anemia in cancer patients
NCT00711958Phase 3Completed
- Sponsor
- Sandoz
- Start
- Nov 2004
- Primary completion
- Jul 2005
- Countries
- 2
01
Overview
A Phase 3 trial of epoetin alfa HX575 in anemia, sponsored by Sandoz. Started Nov 2004; status: completed.
02
Drugs
epoetin alfa HX575
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00711958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711958.